secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001641172-25-010495
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab Q1 revenue up 32% to $645K; gross margin expands to 66.6%
----------------------------------------------------------------

- Total revenue $645,419 vs $488,587 in Q1 2024, a 32.1% increase.
- Gross margin improved to 66.6% from 58.6% on favorable product mix.
- ISP revenue rose 28% to $162,502; Allergy Diagnostics up 11.7% to $264,913.
- New clinical study performance obligations contributed $89,100 in revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000164117225010495/0001641172-25-010495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000164117225010495/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-010495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer